Zocdoc

Zocdoc Competitive Intelligence & Landscape

zocdoc.com ·

Overview

Zocdoc Overview

Zocdoc, Inc. is a private healthcare technology company founded in 2007 and headquartered in New York City. It operates a comprehensive online healthcare marketplace that enables patients to find, review, and book in-person or virtual appointments with doctors and dentists who accept their insurance (Wikipedia, Exa). The platform is designed to improve access to healthcare by offering real-time availability, verified reviews, and appointment booking within 24 to 72 hours, making healthcare more accessible and convenient for users.

Zocdoc’s core services include an appointment scheduling platform that caters to a wide target market, including individual practices, large healthcare systems, and health organizations across the United States. Its services support both patients seeking timely care and healthcare providers aiming to grow their practice, reduce no-shows, and optimize scheduling (Wikipedia, Exa). As of 2026, the company employs around 800 to 983 staff members, with a valuation supported by over $375 million in funding, and it continues to expand its digital health offerings (PitchBook, Tracxn).

Zocdoc’s mission emphasizes empowering patients with easy access to healthcare and supporting providers with innovative tools to enhance patient experience and practice growth. Its value proposition centers on simplifying healthcare access, reducing appointment wait times, and fostering a more efficient healthcare ecosystem (Exa). Overall, Zocdoc remains a leading player in the telehealth and healthcare marketplace sectors, committed to transforming the patient-provider interaction through technology.

Zocdoc

Zocdoc Weekly Intel Updates

Receive weekly intel updates about Zocdoc straight to your inbox.

Competitors

Zocdoc Competitors

NexHealth is a prominent competitor to Zocdoc, offering a comprehensive healthcare platform that emphasizes better control, seamless integration, and improved patient engagement. Unlike Zocdoc's pay-per-booking model, NexHealth provides more flexible pricing options and features tailored for both small practices and large healthcare systems, making it attractive for providers seeking cost predictability and customization (NexHealth).

Healthgrades is another major player, focusing on reputation management and patient reviews alongside appointment scheduling. It positions itself as a trusted source for patient education and provider comparison, leveraging a large consumer base to help practices attract new patients through enhanced visibility and credibility (Healthgrades). Compared to Zocdoc, Healthgrades emphasizes reputation and patient trust, often commanding higher market share in patient acquisition.

Doximity is a professional network for healthcare providers that also offers appointment scheduling and telehealth services. Its key differentiator is its focus on provider-to-provider communication and collaboration, making it more appealing for healthcare professionals who prioritize peer networking alongside patient engagement. Doximity's integration with electronic health records (EHR) and its targeted approach give it an edge over Zocdoc in certain segments (Doximity).

SimplePractice caters primarily to mental health and therapy practices, offering specialized scheduling, billing, and telehealth features. Its market positioning is niche-focused, providing tailored solutions for mental health professionals, which sets it apart from Zocdoc's broader healthcare provider base. Its competitive advantage lies in its user-friendly interface and industry-specific tools, often at a lower cost (SimplePractice).

CareCloud is a healthcare technology platform that combines practice management, electronic health records, and revenue cycle management with appointment scheduling. Its comprehensive suite appeals to larger practices and healthcare organizations seeking an all-in-one solution, positioning itself as a more integrated alternative to Zocdoc’s booking platform (CareCloud).

Product & Pricing

Zocdoc Product and Pricing Intelligence

Zocdoc's product and pricing model primarily operate on a pay-per-booking basis, where healthcare providers are charged only when a new patient books an appointment through the platform (Zocdoc Blog). As of late 2025, Zocdoc does not list fixed monthly plans or tiers publicly, but providers are billed per booking, with fees varying by specialty and location. The typical fee ranges from approximately $35 to $110 per new patient booking, depending on the region and specialty, and there are no subscription or free plans available (TrustRadius). Recent changes in 2026 have reinforced this model, emphasizing the pay-per-booking structure without offering free trials or tiered subscription plans. Some alternative platforms, such as Vosita, offer flat-fee monthly pricing starting at $69-$99 per provider with unlimited bookings, providing a more predictable cost structure (RightPatient). Overall, Zocdoc's current pricing emphasizes variable, booking-based charges rather than fixed tiers or free features, making it a flexible but potentially unpredictable investment for healthcare practices.

Ad Campaigns

Zocdoc Ad Campaigns

Zocdoc is currently running 4,087 ads across Google, LinkedIn — 4,000 on Google and 87 on LinkedIn. Explore Zocdoc's live ad creative, messaging, and the platforms they advertise on in the ad library — updated automatically by ForesightIQ.

See of Zocdoc's ads

View ads

Hiring & Layoffs

Zocdoc Hiring and Layoffs

As of mid-2025, Zocdoc has maintained a stable workforce of approximately 796 employees, with recent hiring activity reflecting a balanced approach to growth and attrition. The company hired 89 new employees year-to-date, representing about 5% of its total workforce, which indicates ongoing recruitment efforts to support its operations and product development (Unify). The company's staffing is primarily concentrated in engineering, sales, and support roles, with a significant portion based in New York City, alongside international teams in India, reflecting a focus on technological innovation and customer acquisition (Unify).

In early 2026, Zocdoc was described as a mission-driven workplace emphasizing growth, collaboration, and patient impact, with a strong culture of radical candor and purpose-driven work. The company actively recruits for various roles, including engineering, marketing, sales, and customer success, indicating a strategic focus on expanding its healthcare marketplace platform (Built In). There have been no reports of layoffs, suggesting that Zocdoc's current hiring patterns signal a strategy aimed at strengthening its core services and scaling its digital health offerings rather than downsizing. Overall, Zocdoc’s hiring trends and company culture reflect a focus on sustainable growth, technological innovation, and a commitment to improving patient experiences in healthcare (Built In NYC).

Leadership

Zocdoc Management and Leadership Team

As of March 2026, Zocdoc's management and leadership team is led by Oliver Kharraz, the founder and CEO of the company, who has been at the helm since its inception. Kharraz's background includes extensive experience in healthcare and information technology, and he is actively involved in guiding the company's strategic direction (The Org).

The executive team also includes Netta Samroengraja as CFO, overseeing financial operations, and Jessica Aptman as Chief Communications Officer, managing the company's communications strategy. Other key leaders include Richard Fine, the Chief Commercial Officer, and Alex Doyne and Ben Perper, both Vice Presidents of Product Management, who play vital roles in product development (The Org).

Recent leadership changes include the appointment of Edward Liu as the new CFO in 2021, bringing experience from Morgan Stanley and McKinsey & Company, to help scale Zocdoc's operations and financial growth (MobiHealthNews). The leadership team is complemented by notable hires at the C-suite level, emphasizing a focus on innovation, growth, and strategic expansion in the digital health space.

Financials

Zocdoc Financial Performance, Fundraising, M&A

As of 2026, Zocdoc has demonstrated significant financial growth and strategic activity. The company has raised a total of approximately $383 million across 13 funding rounds, with the latest being a Series E round of $150 million in February 2021, which valued the company at an estimated $1.8 billion in 2015 (CB Insights). Although recent revenue figures are not publicly available beyond 2015, that year Zocdoc generated around $71 million in revenue (CB Insights). The company's valuation has been reported to be around $1.8 billion as of 2015, and it continues to be classified as a unicorn, indicating a valuation above $1 billion (Tracxn).

In terms of business evolution, Zocdoc shifted from a subscription-based model to a platform model in 2018, allowing providers to pay per new patient booking, which contributed to exponential growth driven by network effects (Summit Health). The company remains privately held and continues to expand its user base, facilitating millions of appointments monthly across the United States, and maintaining its position as a leading healthcare marketplace (Oyelabs). While detailed recent financial health indicators are not publicly disclosed, the company's ongoing fundraising and valuation suggest strong investor confidence and sustained growth.

Partnerships

Zocdoc Partnerships, Clients and Vendors

Zocdoc has established numerous notable partnerships, particularly with electronic health records (EHR) and practice management software vendors, to enhance healthcare provider workflows and patient scheduling. In 2024, Zocdoc launched an advanced partner program aimed at deepening these collaborations, enabling over 175 calendar integrations with EHRs and PMSs to facilitate real-time appointment availability and online scheduling for providers across various specialties (Healthcare IT News).

Key enterprise clients include Eyefinity, a leader in eye care practice management, which integrated Zocdoc’s platform to expand patient access and streamline appointment booking, and Blue Shield of California, which partnered with Zocdoc to power in-network scheduling within its member portal, marking a significant collaboration with a major health plan (PR Newswire, VSP Vision). Additionally, Zocdoc has partnered with Healthgrades, a prominent healthcare provider discovery platform, to enable real-time appointment booking, improving access for millions of patients (PR Newswire).

These ecosystem relationships highlight Zocdoc’s strategic focus on integrating with major EHRs, practice management systems, and healthcare portals to create a seamless booking experience, expand its ecosystem, and enhance healthcare delivery through technology integrations (Healthcare IT News). As of 2026, Zocdoc continues to strengthen these partnerships, leveraging its extensive network to improve patient access and provider efficiency.

Events

Zocdoc Event Participations

Zocdoc actively participates in various industry events, conferences, and community initiatives to promote healthcare innovation and connect with professionals. Notably, Zocdoc has been involved in prominent conferences such as QCon New York, where they presented on topics like cloud architecture and machine learning powering their search system, showcasing their commitment to technological advancement in healthcare (QCon New York).

Additionally, Zocdoc has been featured in webinars and industry discussions, such as those organized by InfoQ, focusing on their search algorithms and platform architecture, which highlights their engagement in knowledge sharing within the tech community (InfoQ). They also participate in community networks like Women in Tech, emphasizing their commitment to diversity and inclusion in the tech industry (Women in Tech Network).

While specific details about all their sponsored or attended events are not exhaustively listed, it is clear that Zocdoc maintains a strong presence at major healthcare and technology conferences, contributing to industry discussions and thought leadership in healthcare technology.

Frequently Asked Questions

What does Zocdoc's 2024 advanced partner program and 175+ EHR/PMS integrations signal about their competitive strategy?

Zocdoc is deliberately repositioning itself as infrastructure for the broader healthcare scheduling ecosystem rather than a standalone consumer destination. By launching an advanced partner program in 2024 and enabling over 175 calendar integrations with EHRs and practice management systems, Zocdoc is embedding itself into provider workflows and health plan portals — including a notable integration with Blue Shield of California — making it harder for competitors to displace. This distribution-layer strategy also explains the Healthgrades partnership, where Zocdoc now powers real-time booking on a rival discovery platform, effectively monetizing traffic it doesn't own.

Is Zocdoc's pay-per-booking pricing model a structural advantage or a vulnerability as competitors like NexHealth offer flat-fee alternatives?

Zocdoc's pay-per-booking model — ranging from roughly $35 to $110 per new patient depending on specialty and region — creates direct cost unpredictability for providers, which is a meaningful vulnerability as flat-fee competitors like NexHealth and Vosita (which starts at $69–$99/month for unlimited bookings) gain traction. For high-volume practices, Zocdoc's variable costs can substantially exceed flat alternatives, giving cost-conscious providers a clear reason to switch. The model's upside is that it aligns Zocdoc's revenue with actual patient acquisition, which can be an easier sell to practices skeptical of paying for unproven value, but the lack of any subscription tier or free plan limits Zocdoc's ability to capture and retain smaller or cost-sensitive practices.

What does Zocdoc's hiring concentration in engineering, sales, and support roles — with no reported layoffs — suggest about their current operational priorities?

Zocdoc's hiring pattern as of mid-2025 — 89 new hires year-to-date against a ~796-person workforce, concentrated in engineering, sales, and support — points to a company in steady-state scaling rather than a restructuring or pivot. The absence of reported layoffs alongside active recruitment in customer-facing and technical roles suggests confidence in revenue trajectory and a focus on deepening product capability and provider acquisition rather than cost reduction. The dual footprint across New York City and India also indicates a maturing engineering organization optimizing for cost-effective technical capacity.

How should corp-dev teams interpret Zocdoc's funding history — a $150M Series E in 2021 with no reported rounds since — relative to its unicorn valuation?

Zocdoc has raised approximately $383 million total, with its last disclosed round being a $150 million Series E in February 2021; its unicorn valuation of $1.8 billion dates to 2015. The absence of a new funding round for four-plus years in a capital-intensive sector suggests either strong enough cash generation to avoid dilution or a deliberate choice to stay private and avoid a down-round in a compressed healthtech valuation environment. For corp-dev teams, this signals a company that may be evaluating strategic alternatives — including acquisition or a delayed IPO — rather than pursuing aggressive venture-backed expansion.

What does Zocdoc's business model shift from subscription to pay-per-booking in 2018 tell us about the sustainability of its current growth?

Zocdoc's 2018 pivot from a subscription model to pay-per-booking was a deliberate bet on network effects: as more patients use the platform, providers gain more bookings and are willing to pay per acquisition rather than a fixed fee. This model generates revenue that scales directly with platform utilization and is described as having driven exponential growth, which supports the logic of the 2021 Series E. However, its sustainability depends on Zocdoc maintaining patient-side demand and provider density simultaneously — a classic two-sided marketplace tension — and the model is increasingly pressured by flat-fee competitors who can offer cost certainty to providers already on the platform.

What does Zocdoc's partnership with Blue Shield of California signal about its go-to-market evolution?

The Blue Shield of California partnership — which integrates Zocdoc's scheduling directly into the health plan's member portal — marks a meaningful go-to-market shift from B2C patient acquisition toward B2B2C distribution through payers. This is strategically significant because health plan partnerships give Zocdoc access to large, pre-authenticated patient populations without bearing the cost of direct consumer acquisition, and they position Zocdoc as a utility embedded in insurance infrastructure. If Zocdoc replicates this model with other major health plans, it could substantially reduce customer acquisition costs while increasing booking volume and provider network density.

How does Doximity's competitive positioning expose a structural gap in Zocdoc's provider-side value proposition?

Doximity targets healthcare providers through professional networking and peer-to-peer communication, creating stickiness that Zocdoc — which operates primarily as a patient-facing booking layer — does not replicate. Doximity's EHR integrations and provider collaboration tools mean it competes for provider attention and wallet share on dimensions Zocdoc doesn't address, particularly for specialists who weight referral networks heavily. This gap suggests Zocdoc's provider retention is primarily transactional (bookings and revenue), making it more vulnerable to churn if a competitor offers comparable patient volume alongside deeper workflow integration.

What does the CFO transition at Zocdoc — Edward Liu hired in 2021 with a Morgan Stanley and McKinsey background — suggest about where the company was headed post-Series E?

Hiring a CFO with investment banking (Morgan Stanley) and management consulting (McKinsey) credentials immediately following a $150 million Series E is a classic signal of a company preparing for either an IPO or a structured M&A process. Edward Liu's background is more consistent with capital markets and strategic transaction preparation than with operational finance optimization, suggesting Zocdoc's board was positioning the company for a liquidity event in the 2022–2024 window. The fact that no IPO or acquisition has been announced since likely reflects the deterioration of healthtech public market valuations rather than a withdrawal of strategic intent.

What does Zocdoc's engagement at engineering conferences like QCon New York — presenting on cloud architecture and ML-powered search — reveal about where its technical differentiation actually lies?

Zocdoc's conference presentations on cloud architecture and machine learning in search suggest that its core technical moat is in matching and discovery — specifically, the algorithms that surface the right provider for a given patient query in real time — rather than in scheduling infrastructure alone. This is a meaningful differentiator because search quality directly determines patient conversion and provider ROI, and ML-driven relevance is harder to replicate than calendar integration. It also implies that Zocdoc's engineering investment is skewed toward demand-side (patient acquisition and intent matching) rather than supply-side (provider tools), which aligns with its marketplace-first business model.

Is Zocdoc's competitive position in mental health scheduling defensible, given SimplePractice's dominance in that vertical?

Zocdoc's competitive position in mental health scheduling appears weak relative to SimplePractice, which offers an integrated practice management, billing, and telehealth suite purpose-built for mental health and therapy providers at predictable pricing. Zocdoc's generalist marketplace model offers patient volume but lacks the specialty-specific workflow tools that mental health practitioners prioritize. Unless Zocdoc develops vertical-specific features or acquires a mental health-focused platform, it is likely to cede this segment to SimplePractice and similar niche players while remaining stronger in primary care and specialist categories with higher booking fees.

What does Zocdoc's stable headcount of ~796 employees alongside its claimed facilitation of millions of monthly appointments suggest about operational leverage in the business?

Facilitating millions of monthly appointments with a workforce of roughly 800 people implies meaningful operational leverage — Zocdoc's marketplace model scales transaction volume without proportional headcount growth, which is consistent with a platform business rather than a services business. The relatively small team concentrated in engineering, sales, and support suggests the heavy lifting is done by software (search, matching, scheduling automation) and partner integrations rather than human intermediaries. This leverage profile supports the pay-per-booking model's margin potential as booking volume grows, though it also means revenue is highly sensitive to platform usage changes without a fixed-cost buffer.

What is the strategic read on Zocdoc powering real-time booking on Healthgrades — a platform that also competes with it for patient discovery?

Zocdoc's decision to power appointment booking on Healthgrades — a direct competitor in the patient-provider discovery space — is a pragmatic distribution play that prioritizes booking volume over channel exclusivity. By becoming the booking engine behind Healthgrades' traffic, Zocdoc monetizes patient intent it would not otherwise capture, while Healthgrades avoids building its own real-time scheduling infrastructure. The risk is that it reinforces Healthgrades' consumer brand while Zocdoc operates invisibly as back-end infrastructure, potentially limiting Zocdoc's ability to differentiate on the patient experience. ForesightIQ tracks these partnership signals as indicators of whether Zocdoc is evolving toward a platform-of-record position or conceding the consumer brand layer to partners.

Powered by ForesightIQ · Competitive intelligence from digital exhaust